Crossmark

Impact of first-line antihypertensive drug class and intensity on NT-proBNP improvement and cardiovascular outcomes among hypertensive patients with pre-heart failure: findings from SPRINT trial

Crossref DOI link: https://doi.org/10.1038/s41440-024-01873-7

Published Online: 2024-10-02

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Lili

Yi, Jiayi

Wang, Wei

Zhou, Zeming

Liu, Jiamin

Zhang, Haibo

Li, Yan

Ren, Xiangpeng

Lu, Jiapeng

Zheng, Xin
License Information

Text and Data Mining valid from 2024-10-02

Version of Record valid from 2024-10-02
More Information

Article History

Received: 10 February 2024

Revised: 23 July 2024

Accepted: 15 August 2024

First Online: 2 October 2024

Compliance with ethical standards

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below